Ron H van Schaik, Professor, Erasmus University, Rotterdam, the Netherlands (5) YouTube
Prof. Dr. Ron van Schaik is hoogleraar Farmacogenetica, en leidt het Internationaal Expertise-laboratorium Farmacogenetica van de Afd. Klinische Chemie. Focus is implementatie van farmacogenetica. Wetenschappelijk onderzoek richt zich op de Oncologie (PGx en ctDNA analyses), Psychiatrie, Transplantatie en de Pijnbestrijding (opioiden.
Interview Prof. Ron H. van Schaik YouTube
Pharmacogenetics International Expertcenter - Prof. Dr. Ron H.N. van Schaik - Erasmus MC Research group/lab | Prof. Dr. Ron H.N. van Schaik Pharmacogenetics International Expertcenter Research is aimed at discovery and implementation of DNA analysis for personalizing drug therapy About our research group/lab Our research Key Publications
Ron van Schaik • BioTech Pharma Summit
Contact External Profile About Introduction Publications Other positions Profile of R.H.N. van Schaik, PhD, Erasmus MC, Rotterdam, Professor Pharmacogenetics.
Interview Ron van Schaik
Simple Summary Although the introduction of programmed cell death 1 (PD-1) immune checkpoint inhibitors (ICIs) has significantly improved the overall survival (OS) in patients with metastatic.
5. SLOVENSKI KONGRES KLINIČNE KEMIJE IN LABORATORIJSKE MEDICINE
Ron H.N. van Schaik Full Professor Pharmacogenetics / Head Dept Clinical Chemistry / Past-President European Society Pharmacogenomics & Personalised Therapy (ESPT) 10mo
Interview Ron van Schaik
Ron van Schaik Cytochrome P450 3A4 (CYP3A4) is the most important drug metabolizing enzyme in the liver, responsible for the oxidative metabolism of ∼50% of clinically prescribed drugs.
Forward Thinking An Interview with Ron Van Schaik PMF Features
Awesome Books: your haven for affordable literary gems. Quality reads, unbeatable prices. Our extensive selection caters to all readers. Discover your next favourite book with us.
Nieuwe inzichten helpen patiënt in strijd tegen depressie Siemens Healthineers Nederland
Prof van Schaik has given over 200 invited lectures and participates on multiple national and international advisory committees on pharmacogenetics In 2001, he received the Ortho Clinical Diagnostics Award for Outstanding Research, in 2009 the AACC Outstanding Speaker Award, and in 2010 the AACC/Mol Pathology Award for Outstanding Scientific Research.
20171222_10Gold Ron van Schaik Flickr
Prof. Dr. Ron van Schaik, PhD is a registered European specialist Laboratory medicine (2003) and a Full Professor of Pharmacogenetics (2013). He is working at the Dept. Clinical Chemistry at the Erasmus University Medical Center Rotterdam, The Netherlands.
Ron H van Schaik, Professor, Erasmus University, Rotterdam, the Netherlands (3) YouTube
Prof. Dr. Ron van Schaik (PhD, FACB) is a registered European Specialist Laboratory Medicine and a Full Professor of Pharmacogenetics. He is working at the Dept. Clinical Chemistry at the Erasmus University Medical Center Rotterdam, and is Director of the International (IFCC) Expert-center for Pharmacogenetics.
Faculty of Pharmaceutical Sciences Ron van Schaik, PhD Michael Smith Laboratories
Andrews, Louise ; Hesselink, Dennis; van Schaik, Ron et al. / A population pharmacokinetic model to predict the individual starting dose of tacrolimus in adult renal transplant recipients.In: British Journal of Clinical Pharmacology. 2019 ; Vol. 85, No. 3. pp. 601-615.
Ron van Schaik Associate Professor Erasmus MC XING
Ron H.N. van Schaik's Post Ron H.N. van Schaik Full Professor Pharmacogenetics / Head Dept Clinical Chemistry / Past-President European Society Pharmacogenomics & Personalised Therapy (ESPT)
Media Tweets by Ron van Schaik (CGA_Web) Twitter
Ron SCHAIK | Cited by 18,852 | of Erasmus MC, Rotterdam (Erasmus MC) | Read 541 publications | Contact Ron SCHAIK
Prof. Dr. Ron H.N. van Schaik Laboratoriumspecialist Erasmus MC
Genetic variation in the multidrug and toxin extrusion 1 transporter protein influences the glucose-lowering effect of metformin in patients with diabetes: a preliminary study. ML Becker, LE Visser, RHN van Schaik, A Hofman, AG Uitterlinden,. Diabetes 58 (3), 745-749. , 2009. 313.
Ron SCHAIK Professor Erasmus MC, Rotterdam Erasmus MC Department of Clinical Chemistry (AKC)
Interview Ron van Schaik 20 mei 2021 'Iedereen heeft recht op een DNA-paspoort' Ron van Schaik Professor farmacogenetica Nederland is vooralsnog het enige land ter wereld waar patiënten bij de apotheek medicatie op maat kunnen krijgen op basis van hun DNA-profiel.
Ronald van Schaik Werf&
New insights were provided by the esteemed keynote speakers, André G. Uitterlinden, Ron H.N. van Schaik, Roos van Westrhenen and all other speakers, Lone Fisker, Jordan Moore, Tiffany Morris, PhD.
